FDA
approval
· 2025-11-14
FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
Summary
FDA approved a supplemental application from Prasco Laboratories for Spironolactone and Hydrochlorothiazide, a combination diuretic. This represents approval of…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE (SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE)